Would you recommend the following article to a politician, an athlete, a business executive, or a scientist?

Third AstraZeneca drug found wanting AstraZeneca faced its third major setback in as many months yesterday after clinical trials dashed expectations that its lung cancer drug Iressa would develop into a blockbuster product that would dominate treatment around the world.
